Literature DB >> 8163804

Neuroleptic malignant syndrome presenting without initial fever: a case report.

V Y Totten1, E Hirschenstein, P Hew.   

Abstract

Neuroleptic malignant syndrome (NMS) is a rare but potentially fatal complication of the use of neuroleptic medications. It is of interest to emergency physicians because rapid recognition of NMS will improve patient outcome and prevent inappropriate treatment. NMS shares features with malignant hyperthermia, serotonin syndrome, lethal catatonia, and heat stroke. We describe a patient with NMS who presented to our institution without initial fever. We review the literature, the classic presentation of NMS, the risk factors, and the morbidity. We discuss the differential diagnosis and the treatment recommendations from the literature.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163804     DOI: 10.1016/0736-4679(94)90011-6

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  4 in total

1.  Neuroleptic malignant syndrome with metoclopramide overdose coexisting with Clostridium difficile diarrhea.

Authors:  Azhar Supariwala; Gunjan Kant; Raymonde E Jean
Journal:  Intensive Care Med       Date:  2011-06-18       Impact factor: 17.440

2.  Neuroleptic malignant syndrome presenting as pulmonary edema and severe bronchorrhea.

Authors:  U Patel; M Agrawal; P Krishnan; S Niranjan
Journal:  J Natl Med Assoc       Date:  2002-04       Impact factor: 1.798

3.  Probable case of neuroleptic malignant syndrome following administration of antituberculotic drugs in a chlorpromazine-treated patient.

Authors:  GeumSook Shim; Do-Hyung Kang; Jun Soo Kwon
Journal:  J Korean Med Sci       Date:  2008-08       Impact factor: 2.153

4.  Diagnosis and implications in the therapeutic management of patient with afebrile neurolepctic malignant syndrome.

Authors:  Rafael Quintes Ducasble Gomes; Amilton Dos Santos-Júnior; Gabriel Augusto de Araujo Silva Dias; Carlos Filinto da Silva Cais
Journal:  Oxf Med Case Reports       Date:  2016-09-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.